Northern Trust’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PRCT
Northern Trust's PRCT Position: Q3 2026 in Review
Northern Trust reduced its Procept Biorobotics (PRCT) stake by 0.75% in Q3 2026, selling an estimated $89.9K and leaving 593,040 shares worth $10.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2097.
Northern Trust first reported a position in PRCT in Q4 2021 and has held it in 20 quarters since. The position peaked at $35.9M in Q4 2024. 229 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.
- Northern Trust held 593,040 shares of Procept Biorobotics worth $10.8M as of Q3 2026.
- Northern Trust sold 4,509 Procept Biorobotics shares in Q3 2026, an estimated $89.9K.
- Procept Biorobotics made up ﹤0.01% of Northern Trust's portfolio in Q3 2026, its #2097 holding.
- Northern Trust first reported a position in Procept Biorobotics in Q4 2021 and has held it in 20 quarters since.
- Northern Trust's Procept Biorobotics position peaked at $35.9M in Q4 2024.
- 229 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.
Based on Northern Trust's 13F filing for Q3 2026, filed 16 Nov 2026.